Immune therapy for ovarian cancer: promise and pitfalls. - Wikidata - wikimedia - TriplyDB

Immune therapy for ovarian cancer: promise and pitfalls.

Immune therapy for ovarian cancer: promise and pitfalls.

http://www.wikidata.org/entity/Q37873928

about

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.Inhibition of Notch 1 receptor influenced the differentiation of Lin-CD45RA-dendritic cell precursors within ovarian carcinoma microenvironment.Formulation and evaluation of oral microparticulate ovarian cancer vaccines.Immunotherapy in ovarian cancer.Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer.

P2860

Q35677893-D793A797-188B-4D09-8C0A-1D023E5A8FBB Q36040386-B0A90B94-C8E4-4E19-9409-651558848DBD Q36212696-6F76FADB-12B7-42BF-B46B-6DCB1451D602 Q36631249-15B3DC01-CCF5-4206-84D2-EE3B1645990C Q36673709-C32D6C13-70C8-4741-B4F0-AFB537933C8A Q36884862-711BE23D-A9D3-44D3-8A5E-9FCA16114C46 Q37225693-1FAD14ED-1706-4EF9-89A9-838EA492A49A Q38866846-8B4B4A05-F40A-4153-A3A5-449959F1A7C1

P2860

Immune therapy for ovarian cancer: promise and pitfalls.

http://www.wikidata.org/entity/Q37873928

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immune therapy for ovarian cancer: promise and pitfalls.

@en

Immune therapy for ovarian cancer: promise and pitfalls.

@nl

type

label

Immune therapy for ovarian cancer: promise and pitfalls.

@en

Immune therapy for ovarian cancer: promise and pitfalls.

@nl

prefLabel

Immune therapy for ovarian cancer: promise and pitfalls.

@en

Immune therapy for ovarian cancer: promise and pitfalls.

@nl

P1433

Q37873928-82A18A95-EE4F-4602-99F0-707BD35A8984

P1476

Q37873928-C497A3A7-6058-4D2B-B753-6EDC1E330F42

P2093

Q37873928-C022F6A3-E105-4C80-B517-F38E2A59AB78

Q37873928-F0DA34DF-8D44-41E7-B0DB-9CBB21B4AE24

P2860

Q37873928-01C27E1F-9381-4224-9071-9CB338A32338

Q37873928-05590A41-8A4F-4FD8-8EE7-668AE7128FBF

Q37873928-0B553BBD-9B77-479A-A930-4BA05BADD9B8

Q37873928-0CA80AA3-E54A-4133-873F-00DCB7450ABC

Q37873928-0EBEAD9C-64A0-40F7-B7D4-78414E6314DA

Q37873928-13E100AE-8F66-4E88-A78A-33CBDDCE5830

Q37873928-184419BC-D62D-43A5-9E6B-7F34E6D039FF

Q37873928-1907FDB3-7D28-45FD-A71B-43FBFFF3D6B9

Q37873928-1AD0CF57-AE9C-4B86-B859-0FD55A39E12C

Q37873928-22C33A70-683B-40A2-999A-BC05B575D3C1

P304

Q37873928-FA136497-2C56-484B-82F9-3DC8B18BC270

P31

Q37873928-B8BB8759-1D9B-4467-B02D-02D6B498CFBD

P356

Q37873928-DE3DC356-997A-47CE-A85F-AB9000493EC6

P433

Q37873928-9D4F6743-14BD-4D68-8FDE-EAEA8D529FC2

P478

Q37873928-D9BD894C-8C48-437B-852F-DD63950B37FC

P577

Q37873928-F7996943-7BF5-478B-BD5A-C2247D37E09E

P698

Q37873928-71F4A9DB-F14C-4D34-B083-46D57411D1DD

P921

Q37873928-4D2F267A-18D2-4483-BD7F-80DC43679CF4

P356

08830185.2011.567361

P1433

International Reviews of Immunology

P1476

Immune therapy for ovarian cancer: promise and pitfalls.

@en

P2093

Suzanne R Thibodeaux

http://www.w3.org/2001/XMLSchema#string

Tyler J Curiel

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Reactivity of a monoclonal antibody with human ovarian carcinoma

CD95 promotes tumour growth

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma

Myeloid-derived suppressor cells as regulators of the immune system

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

The three Es of cancer immunoediting

Cancer despite immunosurveillance: immunoselection and immunosubversion

Interferons, interferon-like cytokines, and their receptors

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

P304

102-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08830185.2011.567361

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21557637

http://www.w3.org/2001/XMLSchema#string

P921